ECE2010 Poster Presentations Steroid metabolism & action (19 abstracts)
Effect of body mass index on differences of sex hormone levels in postmenopausal women receiving low-dose hormone therapy
Irene Lambrinoudaki 1 , Eleni Armeni 1 , Demetrios Rizos 2 , Panagiotis Kofinakos 1 , George Kaparos 2 , Andreas Alexandrou 3 , Maria Creatsa 1 , Emanuel Logothetis 2 , Dimitra Papadimitriou 1 , Efstratios Tsakonas 1 & Evangelia Kouskouni 2
1Second Department of Obstetrics and Gynecology, Aretaieio Hospital, University of Athens, Athens, Greece; 2Hormonal and Biochemical Laboratory, Aretaieio Hospital, University of Athens, Athens, Greece; 3First Department of Surgery, Laiko Hospital, University of Athens, Athens, Greece.
Objective: To investigate the effect of BMI on the absolute change from baseline levels in circulating sex hormone in postmenopausal women treated with oral continuous combined low dose HT for 6 months.
Design: The study recruited 36 postmenopausal women who received daily E2 1 mg/NETA 0.5 mg for 6 months. Hormonal assessment included measures of serum concentrations of FSH, LH, 17β-estradiol and free estrogen index (FEI), total and free testosterone (FAI), Δ4-Androstendione, SHBG and DHEA-S before treatment and after 6 months of treatment. We compared percental changes of hormone levels from baseline and mean absolute hormone concentrations between lean and overweight women.
Results: Lean subjects had statistically significant higher increments of FEI compared to overweight (lean women: 0.1±0.09 at baseline, and 0.3±0.1 at final levels, Δ=181%; overweight women: 0.2±0.1 at baseline, and 0.4±0.3 at final levels, Δ=87%, P=0.034). Mean 17β-estradiol increased in both groups at statistical significant levels (lean women: 22.4±12.0 pg/ml at baseline, and 45.9±20.7 pg/ml at final levels, Δ=105%, P=0.006; overweight women: 22.4±8.7 pg/ml at baseline 58.4±23.4 pg/ml at final levels, Δ=161%, P=0.0001; P(Δ%) between groups=0.619). Mean levels of FSH decreased significantly in both groups (lean women: Δ=−45%, P=0.0001; overweight women: Δ=–39%, P=0.003; P(Δ%) between groups=0.661).
Conclusions: Concentrations of free estrogens increase more sharply in lean women being under treatment with oral low-dose HT. BMI did not influence the changes of total 17β-estradiol levels from baseline. This finding might in part explain the vulnerability of lean women under HT to develop breast cancer.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more